Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr180 Inhibitors

Olr180 inhibitors represent a chemical class of compounds that specifically target and modulate the activity of the Olr180 receptor. Olr180, part of the olfactory receptor (OR) family, is a G-protein-coupled receptor (GPCR) primarily involved in the detection of odor molecules. These receptors play a pivotal role in the olfactory system by transducing chemical signals from odorants into neuronal responses, enabling the sense of smell. The inhibition of Olr180 receptors is achieved through compounds that interact with the receptor's active site or allosteric sites, effectively preventing the receptor from binding to its natural ligands or altering its conformational state. This modulation of Olr180 can be highly specific, depending on the structure of the inhibitor, which typically mimics or competes with natural odorants or employs unique chemical scaffolds that interfere with receptor activity.

The structural chemistry of Olr180 inhibitors is of particular interest in the field of molecular biology and receptor pharmacology. These inhibitors are often characterized by their ability to maintain high specificity and affinity for the Olr180 receptor, a feature that is crucial in studying the receptor's function in a controlled manner. The chemical architecture of these inhibitors may include aromatic rings, heterocyclic cores, and various functional groups that enhance receptor binding through hydrogen bonding, hydrophobic interactions, and Van der Waals forces. Additionally, the development of Olr180 inhibitors involves rigorous screening and synthesis processes, where structure-activity relationship (SAR) studies are crucial to optimizing their efficacy. This class of compounds serves as valuable tools in the exploration of olfactory receptor signaling pathways, aiding in the broader understanding of GPCR function and the molecular mechanisms underlying olfaction.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Proteasome inhibitor, may impact protein degradation processes involving Olr180.

Dabrafenib

1195765-45-7sc-364477
sc-364477A
sc-364477B
sc-364477C
sc-364477D
5 mg
25 mg
50 mg
100 mg
10 g
$141.00
$260.00
$278.00
$411.00
$12485.00
6
(1)

BRAF inhibitor, potentially affects pathways linked to Olr180's activity.

MDV3100

915087-33-1sc-364354
sc-364354A
5 mg
50 mg
$245.00
$1051.00
7
(1)

Androgen receptor inhibitor, could influence hormone signaling pathways affecting Olr180.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

BCR-ABL tyrosine kinase inhibitor, might affect signaling pathways relevant to Olr180.

Lapatinib

231277-92-2sc-353658
100 mg
$420.00
32
(1)

Dual EGFR and HER2 inhibitor, may disrupt growth factor signaling involving Olr180.

Niraparib

1038915-60-4sc-507492
10 mg
$150.00
(0)

PARP inhibitor, potentially affects DNA repair pathways linked to Olr180.

Palbociclib

571190-30-2sc-507366
50 mg
$321.00
(0)

CDK4/6 inhibitor, could impact cell cycle regulation pathways involving Olr180.

Sunitinib Malate

341031-54-7sc-220177
sc-220177A
sc-220177B
10 mg
100 mg
3 g
$197.00
$520.00
$1093.00
4
(1)

Multi-kinase inhibitor, might modulate various signaling pathways involving Olr180.

ABT-199

1257044-40-8sc-472284
sc-472284A
sc-472284B
sc-472284C
sc-472284D
1 mg
5 mg
10 mg
100 mg
3 g
$118.00
$337.00
$520.00
$832.00
$1632.00
10
(0)

BCL-2 inhibitor, may influence apoptosis pathways potentially linked to Olr180.